Stay updated on Idarubicin, Cytarabine, Nivolumab in MDS/AML Clinical Trial

Sign up to get notified when there's something new on the Idarubicin, Cytarabine, Nivolumab in MDS/AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Idarubicin, Cytarabine, Nivolumab in MDS/AML Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2025-03-11T04:19:29.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2025-03-03T23:30:08.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-24T20:43:28.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Difference
    0.6%
    Check dated 2025-02-17T14:52:19.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    2%
    Check dated 2025-02-10T09:45:47.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.1 to 2.14.2.
    Difference
    0.3%
    Check dated 2025-02-03T07:35:17.000Z thumbnail image

Stay in the know with updates to Idarubicin, Cytarabine, Nivolumab in MDS/AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Idarubicin, Cytarabine, Nivolumab in MDS/AML Clinical Trial page.